Skip to content
DataLookout
Menu

NCT06878391

ISB With SSNB & ANB

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints: details revised at 1 of 7 entries
  2. Notable Eligibility criteria expanded, about 9 words Show 7 more changesShow less
    • Trial completed
    • Final enrollment: 48 participants (planned 100)
    • Primary completion date changed from estimate of Jan 31, 2027 to Mar 21, 2026
    • Study sites: 2 to 1
    • Study completion date changed from estimate of Jan 31, 2027 to Sep 21, 2026
    • Secondary endpoints: 9 to 7
    • Publications: details revised at 2 of 2 entries
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Start date changed from estimate of Mar 11, 2025 to Mar 24, 2025
    • Publications: details revised at 2 of 2 entries
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

visual analog pain scale (VAS)
Timeframe: preoperative, postoperative 1, 3, 6, 12, 18, 24, 36, 48 hour(s)

Secondary (7)

Patient's satisfaction (SAT)
IL-6
IL-8
IL-1β
Substance P
Show 2 moreShow less
Serotonin
β -endorphin

Arms and interventions

ISB with SSNB & ANBExperimental

An ultrasound-guided interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) is performed immediately before arthroscopic rotator cuff repair , along with suprascapular nerve block and axillary nerve block (each with 10 ml of 0.75% ropivacaine). Patient Controlled Analgesia (PCA) at a low fixed dose: fentanyl-loading dose: 0.4㎍/kg, continuous dose: 0.2㎍/kg/h, nefopam-loading dose: 0.04mg/kg, continuous dose: 0.02mg/kg/h

ISB with placebo SSNB & ANBPlacebo comparator

An ultrasound-guided interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) is performed immediately before arthroscopic rotator cuff repair , along with suprascapular nerve block and axillary nerve block (each with 10 ml of saline). Patient Controlled Analgesia (PCA) at a low fixed dose: fentanyl-loading dose: 0.4㎍/kg, continuous dose: 0.2㎍/kg/h, nefopam-loading dose: 0.04mg/kg, continuous dose: 0.02mg/kg/h

Procedures: Preemptive ultrasound-guided interscalene brachial plexus block and suprascapular nerve block and axillary nerve block

Sites

1 site in 1 country

  • Hallym University Chuncheon Sacred Heart HospitalChuncheon, Gangwon-do, South Korea